National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 65784 [2022-23692]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
65784
Federal Register / Vol. 87, No. 210 / Tuesday, November 1, 2022 / Notices
• New Attachments Prior
Authorization Infrastructure Rule;
• New Attachments Prior
Authorization Data Content Rule;
• New Attachments Health Care
Claims Infrastructure Rule;
• New Attachments Health Care
Claims Data Content Rule.
Section 1104 of ACA amended HIPAA
by introducing the requirement to adopt
operating rules to support the business
function of each HIPAA-adopted
standard transaction. HHS has adopted
operating rules for the eligibility, claim
status, electronic remittance advice, and
electronic funds transfer transactions.
HHS has not yet adopted operating rules
for health care claims, enrollment/
disenrollment, premium payments,
prior authorization for referrals, or
health care claim attachments
transactions.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Additional Opportunity To Provide
Comment
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trials SEP (UG3, U24, R34).
Date: November 30, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7085,
zhihong.shan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
In addition to the January 18–19,
2023, hearing and RFC, the Committee
is collaborating with the Workgroup for
Electronic Data Interchange (WEDI) in
its role as advisor to the Secretary of
Health and Human Services (HHS).
WEDI is considered an authority on the
use of health information technology
(HIT) to improve health information
exchange. Its membership includes a
cross-section of HIPAA covered entities
that implement the HIPAA standards
and operating rules, as well as vendors
and other subject matter experts who
support those implementations. WEDI is
supporting NCVHS’ efforts to obtain
input from a diverse group of
stakeholders through educational
programs, its annual conference October
25–27, 2022, and other organized
information gathering activities. WEDI
will compile and analyze this
information and share the results with
NCVHS by early December 2022.
Additional information regarding the
WEDI conference and its upcoming
outreach efforts is available at: https://
www.wedi.org/about-us/ and https://
members.wedi.org/event-calendar. The
results of WEDI’s upcoming
information-gathering activities will be
presented during NCVHS’s January 18–
19, 2023, hearing.
Sharon Arnold,
Associate Deputy Assistant Secretary, Science
and Data Policy, Office of the Assistant
Secretary for Planning and Evaluation.
[FR Doc. 2022–23678 Filed 10–31–22; 8:45 am]
BILLING CODE 4150–05–P
VerDate Sep<11>2014
19:39 Oct 31, 2022
Jkt 259001
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: October 26, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–23686 Filed 10–31–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
R13 Conference Grant Review.
Date: December 1, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Tony L Creazzo, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 207–Q,
Bethesda, MD 20892–7924, (301) 827–7913,
creazzotl@mail.nih.gov
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Diversity Training Grants.
Date: December 6, 2022.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific
Review Officer, Office of Scientific Review/
DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208–S, Bethesda, MD
20892, (301) 435–0270, sun.saret@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Catalyze: Enabling Technologies.
Date: December 14, 2022.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Kristin Goltry,
Ph.D.,Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 209–
B, Bethesda, MD 20892, (301) 435–0297,
goltrykl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood 2 Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 26, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–23692 Filed 10–31–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\01NON1.SGM
01NON1
]]>Agencies
[Federal Register Volume 87, Number 210 (Tuesday, November 1, 2022)]
[Notices]
[Page 65784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23692]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel R13 Conference Grant Review.
Date: December 1, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Tony L Creazzo, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 207-Q, Bethesda, MD 20892-7924, (301) 827-7913,
[email protected]
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel Diversity Training Grants.
Date: December 6, 2022.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-S, Bethesda, MD 20892, (301) 435-0270, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel Catalyze: Enabling Technologies.
Date: December 14, 2022.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Kristin Goltry, Ph.D.,Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
209-B, Bethesda, MD 20892, (301) 435-0297, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood 2 Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: October 26, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-23692 Filed 10-31-22; 8:45 am]
BILLING CODE 4140-01-P
